- 2016
- Press releases - 25.10.2016
The French are overweight – confirmed by the Constances cohort
Nearly one in two French people over 30 years of age are overweight. This is what the first results from the Constances cohort has revealed. Now supported by Inserm and the French national social security organisation for salaries workers (Cnamts), Constances collates health data on more than 110,000 French people. With ultimately 200,000 people monitored, Constances will provide varied indicators of health in the population, such as the influence of various factors on the occurrence of disease or the impact of preventive measures.
- Press releases - 25.10.2016
Science Machina: A CEA and Inserm exhibition
Explore the outer limits of the brain and matter, create unlimited energy, overcome pain, simulate the unattainable, etc. subjects dear to science fiction that are a now a reality for research laboratories!
- Press releases - 24.10.2016
Global consortium receives €12 million to combat the Zika virus
ZIKAlliance, a multidisciplinary and multinational research consortium coordinated by Inserm, has received €12 million from the European Union’s Horizon 2020 research and innovation programme to conduct a large-scale 3-year research project on Zika virus (ZIKV) infection in Latin America and the Caribbean.
- Press releases - 20.10.2016
Gastroenteritis is back in metropolitan France
According to the Sentinelles network’s weekly bulletin of 19 October 2016, the incidence rate of acute diarrhoea reached epidemic levels in metropolitan France last week, with 155 cases observed in general medicine clinics per 100 000 inhabitants.
- What's on? - 20.10.2016
Gastroenteritis is back in metropolitan France
Sentinelles network’s bulletin of 19 October 2016 According to the Sentinelles network’s weekly bulletin of 19 October 2016, the incidence rate of acute diarrhoea reached epidemic levels in metropolitan France last week, with 155 cases observed in general medicine clinics per 100 000 inhabitants. The Sentinelles network adds that the current level of gastroenteritis is […]
- Press releases - 19.10.2016
Hepatitis C virus observed under a microscope for the first time
Scientists have finally observed the hepatitis C virus (or HCV) using an electron microscope. This is the first time since the virus became known in 1990. Inserm researchers at Tours (Inserm unit 966, “HIV and Hepatitis Viruses: Morphogenesis and Antigenicity”) have taken other scientists by surprise, including an American team believed to have accomplished this feat in 2013. The latter had in fact misunderstood the nature of the particles observed.
This research is published in the journal Gut.
- Press releases - 13.10.2016
Combating Ebola: Encouraging Results for the PREVAIL Clinical Trial
An international research team involving Inserm and the National Institutes of Health (NIH) has just published the results of the PREVAIL study on treatment for the Ebola virus. While not definitive, the results show that ZMapp may benefit patients with the Ebola virus disease.
These results are published in The New England Journal of Medicine.
- Press releases - 07.10.2016
Rituximab effective in the treatment of membranous glomerulonephritis
A national trial on membranous glomerulonephritis in 80 patients was coordinated by Prof. Pierre Ronco, of the Department of Nephrology and Dialysis at Tenon Hospital AP-HP, of the Inserm Unit “Rare and common kidney diseases, matrix remodelling and tissue repair” [1] and Pierre and Marie Curie University, and by Dr Karine Dahan, of the Nephrology Day Hospital at Tenon Hospital AP-HP. This serious autoimmune disease is the most common cause of nephrotic syndrome in adults. In 30% of cases, it progresses to very severe renal failure. Conducted in collaboration with Prof. Tabassome Simon, from the Department of Clinical Pharmacology and East Paris Clinical Research Centre at Saint Antoine Hospital, AP-HP, this trial shows, for the first time, the efficacy and safety of rituximab in treating the disease.
- Press releases - 06.10.2016
New immunotherapy-based approach for post-transplant leukaemia relapse
An Inserm team from the Mondor Institute for Biomedical Research (IMRB) has just identified a key switch in the immune response, and proposes a new immunotherapy-based approach for combating leukaemia. And maybe other cancers in time. This work is published in the journal Blood.
- News in brief - 05.10.2016
Exhibition « La Science a du gout »
Let’s discover how to eat well to live better! A fun-filled, tasty and interactive exhibition about the joy of eating, balanced diet and health. Meet our scientists, learn while you play, and let your senses guide you through the workshops! The Ministry of Higher Education and Research, INRA and Inserm invite you to this exhibition, […]